Emergent Biosolutions Inc (EBS)
R&D Expenses
$45.30M
TTM · Period ending: · USD
EBS R&D Expenses
Latest reported$45.30Mperiod ending
Latest reported$45.30Mperiod ending
EBS TTM R&D Expenses ($179.60M → $45.30M)
TTM R&D Expenses
High-resolution chart · PNG
EBS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 45,300,000 | |
| 49,100,000 | |
| 53,800,000 | |
| 50,800,000 | |
| 51,100,000 | |
| 70,800,000 | |
| 70,700,000 | |
| 91,000,000 | |
| 92,500,000 | |
| 85,800,000 | |
| 111,400,000 | |
| 129,000,000 | |
| 155,900,000 | |
| 182,600,000 | |
| 188,300,000 | |
| 224,300,000 | |
| 231,700,000 | |
| 227,900,000 | |
| 234,000,000 | |
| 210,500,000 | |
| 245,300,000 | |
| 244,300,000 | |
| 234,500,000 | |
| 237,800,000 | |
| 206,800,000 | |
| 222,800,000 | |
| 226,200,000 | |
| 215,400,000 | |
| 199,000,000 | |
| 159,800,000 | |
| 142,800,000 | |
| 119,314,000 | |
| 104,973,000 | |
| 106,024,000 | |
| 97,400,000 | |
| 96,003,000 | |
| 100,532,000 | |
| 102,674,000 | |
| 108,291,000 | |
| 106,527,000 | |
| 113,518,000 | |
| 106,577,000 | |
| 119,186,000 | |
| 132,298,000 | |
| 142,826,000 | |
| 159,275,000 | |
| 150,829,000 | |
| 142,358,000 | |
| 126,588,000 | |
| 119,465,000 | |
| 119,933,000 | |
| 125,884,000 | |
| 124,337,000 | |
| 124,704,000 | |
| 120,226,000 | |
| 113,657,000 | |
| 115,483,000 | |
| 116,319,000 | |
| 124,832,000 | |
| 125,071,000 | |
| 117,011,000 | |
| 104,132,000 | |
| 89,295,000 | |
| 78,906,000 | |
| 76,522,000 | |
| 78,600,000 | |
| 74,588,000 | |
| 69,524,000 | |
| 67,379,000 | |
| 63,905,000 | |
| 59,470,000 | |
| 57,577,000 | |
| 53,727,000 | |
| 49,863,000 | |
| 53,958,000 | |
| 60,550,000 | |
| 56,653,000 | |
| 43,311,000 | |
| 27,741,000 | |
| 8,880,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 57,600,000 | |
| 107,200,000 | |
| 133,200,000 | |
| 179,600,000 | |
| 179,600,000 |